Osaka, Japan

Takeo Kuratsu

This inventor holds 1 USPTO granted patent. Top assignee: Ono Pharmaceutical Co., Ltd.. Active years: 1977.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Takeo Kuratsu. Retrieved from https://idiyas.com/inventor/takeo-kuratsu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 1977

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Takeo Kuratsu

Introduction: Takeo Kuratsu is a notable inventor based in Osaka, Japan. He has made significant contributions to the field of biochemistry, particularly in the production of cholesterol oxidase. His work has implications for various applications in medicine and biotechnology.

Latest Patents: Takeo Kuratsu holds a patent for a process for producing cholesterol oxidase. This innovative process involves cultivating Schizophyllum commune (IFO 4928) in a culture medium and extracting the cholesterol oxidase from the culture filtrate. This patent highlights his expertise in enzymatic processes and their applications.

Career Highlights: Kuratsu is associated with Ono Pharmaceutical Co., Ltd., a leading company in the pharmaceutical industry. His work at Ono has allowed him to focus on research and development, contributing to advancements in drug formulation and production.

Collaborations: Throughout his career, Takeo Kuratsu has collaborated with esteemed colleagues such as Fumio Hirata and Hiroshi Shimizu. These collaborations have fostered a productive environment for innovation and research.

Conclusion: Takeo Kuratsu's contributions to the field of biochemistry, particularly through his patent on cholesterol oxidase, demonstrate his commitment to advancing scientific knowledge and applications. His work continues to influence the pharmaceutical industry and beyond.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…